WCG’s President of Institutions & Institutional Services, Stuart Horowitz, PhD, MBA, discusses the encouragement of the Accelerated Clinical Trial Agreement (ACTA) for its 1,200 member institutions in an interview with Outsourcing-Pharma.com’s editor, Zachary Brennan.

Publication: Outsourcing-Pharma.com

To read the article, click here.

Print Friendly